Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients

Journal of Diabetes and its Complications

Volumn 28, Issue 3, 2014, Pages 353-359

  Jenkins, Alicia J ^a,b   Fu, Dongxu ^a   Azar, Madona ^c   Stoner, Julie A ^d   Kaufman, Derrick G ^e   Zhang, Sarah ^c,f   Klein, Richard L ^g   Lopes Virella, Maria F ^g   Ma, Jian Xing ^h   Lyons, Timothy J ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e HINES VA HOSPITAL   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardio vascular risk factors; PEDF; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; PIGMENT EPITHELIUM DERIVED FACTOR; ROSIGLITAZONE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; GLOMERULUS FILTRATION RATE; INCIDENCE; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; EYE PROTEINS; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SERPINS;

EID: 84899550859     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.01.008     Document Type: Article

References (51)

1. C. Abraira, W. Duckworth, M. McCarren, N. Emanuele, D. Arca, and D. Reda et al. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial Journal of Diabetes and its Complications 17 6 2003 314 322
2. S. Akin, D.Y. Aksoy, N. Cinar, K. Aydin, E. Karaagaoglu, and M. Ariyurek et al. Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin Clinical Endocrinology 77 6 2012 852 856
3. A. Bohm, A.M. Ordelheide, J. Machann, M. Heni, C. Ketterer, and F. Machicao et al. Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels PLoS One 7 3 2012 e34035
4. M.L. Borg, Z.B. Andrews, E.J. Duh, R. Zechner, P.J. Meikle, and M.J. Watt Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase Diabetes 60 5 2011 1458 1466
5. S.S. Chavan, L.K. Hudson, J.H. Li, M. Ochani, Y. Harris, and N.B. Patel et al. Identification of pigment epithelium-derived factor as an adipocyte-derived inflammatory factor Molecular Medicine 18 2012 1161 1168
6. C. Chen, A.W. Tso, L.S. Law, B.M. Cheung, K.L. Ong, and N.M. Wat et al. Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: A 10-year prospective study Journal of Clinical Endocrinology and Metabolism 95 11 2010 5074 5081
7. H. Chen, Z. Zheng, R. Li, J. Lu, Y. Bao, and X. Ying et al. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy American Journal of Nephrology 32 1 2010 47 56
8. C. Chung, J.A. Doll, A.K. Gattu, C. Shugrue, M. Cornwell, and P. Fitchev et al. Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL) Journal of Hepatology 48 3 2008 471 478
9. C. Chung, J.A. Doll, V.M. Stellmach, J. Gonzales, S. Surapureddi, and M. Cornwell et al. Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha Advances in Experimental Medicine and Biology 617 2008 591 597
10. S. Crowe, L.E. Wu, C. Economou, S.M. Turpin, M. Matzaris, and K.L. Hoehn et al. Pigment epithelium-derived factor contributes to insulin resistance in obesity Cell Metabolism 10 1 2009 40 47
11. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H. Xu, and W. Benedict et al. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis Science 285 5425 1999 245 248
12. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, and P.D. Reaven et al. Glucose control and vascular complications in veterans with type 2 diabetes The New England Journal of Medicine 360 2 2009 129 139
13. S. Famulla, D. Lamers, S. Hartwig, W. Passlack, A. Horrighs, and A. Cramer et al. Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells International Journal of Obesity 35 6 2011 762 772
14. S. Filleur, T. Nelius, W. de Riese, and R.C. Kennedy Characterization of PEDF: A multi-functional serpin family protein Journal of Cellular Biochemistry 106 5 2009 769 775
15. A.K. Gattu, A.L. Birkenfeld, F. Jornayvaz, J. Dziura, F. Li, and S.E. Crawford et al. Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients Acta Diabetologica 49 Suppl. 1 2012 S161 S169
16. S.H. Golden, A. Brown, J.A. Cauley, M.H. Chin, T.L. Gary-Webb, and C. Kim et al. Health disparities in endocrine disorders: Biological, clinical, and nonclinical factors - an Endocrine Society scientific statement Journal of Clinical Endocrinology and Metabolism 97 9 2012 E1579 E1639
17. Y. Ide, T. Matsui, Y. Ishibashi, M. Takeuchi, and S. Yamagishi Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation Microvascular Research 80 2 2010 227 232
18. Y. Ishibashi, T. Matsui, K. Ohta, R. Tanoue, M. Takeuchi, and K. Asanuma et al. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation Microvascular Research 85 2013 54 58
19. A.J. Jenkins, S.X. Zhang, K.G. Rowley, C.S. Karschimkus, C.L. Nelson, and J.S. Chung et al. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes Diabetic Medicine 24 12 2007 1345 1351
20. A. Jenkins, S.X. Zhang, A. Gosmanova, C. Aston, A. Dashti, and M.Z. Baker et al. Increased serum pigment epithelium derived factor levels in type 2 diabetes patients Diabetes Research and Clinical Practice 82 1 2008 e5 e7
21. Y. Liu, L.F. Leo, C. McGregor, A. Grivitishvili, C.J. Barnstable, and J. Tombran-Tink Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice Molecular Medicine 18 2012 1387 1401
22. S. Maeda, T. Matsui, M. Takeuchi, Y. Yoshida, R. Yamakawa, and K. Fukami et al. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis Pharmacological Research 63 3 2011 241 248
23. T. Mao, L. Gao, H. Li, and J. Li Pigment epithelium-derived factor inhibits high glucose induced oxidative stress and fibrosis of cultured human glomerular mesangial cells Saudi Medical Journal 32 8 2011 769 777
24. K. Matsuyama, N. Ogata, M. Matsuoka, C. Shima, M. Wada, and N. Jo et al. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy Molecular Vision 14 2008 992 996
25. N. Mohan, F. Monickaraj, M. Balasubramanyam, M. Rema, and V. Mohan Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy Journal of Diabetes and its Complications 26 5 2012 435 441
26. J.M. Moreno-Navarrete, V. Touskova, M. Sabater, M. Mraz, J. Drapalova, and F. Ortega et al. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance International Journal of Obesity 37 9 2013 1230 1237
27. Y. Motomiya, S. Yamagishi, H. Adachi, and A. Abe Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease Clinical Chemistry 52 10 2006 1970 1971
28. P. Murugeswari, D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease Retina 28 6 2008 817 824
29. K. Nakamura, S. Yamagishi, H. Adachi, Y. Kurita-Nakamura, T. Matsui, and H. Inoue Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes Diabetes/Metabolism Research and Reviews 25 1 2009 52 56
30. K. Nakamura, S. Yamagishi, H. Adachi, T. Matsui, Y. Kurita, and T. Imaizumi Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension International Journal of Cardiology 143 1 2010 96 98
31. N. Ogata, M. Matsuoka, K. Matsuyama, C. Shima, A. Tajika, and T. Nishiyama et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy Journal of Clinical Endocrinology and Metabolism 92 3 2007 1176 1179
32. K. Park, J. Jin, Y. Hu, K. Zhou, and J.X. Ma et al. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization The American Journal of Pathology 178 2 2011 688 698
33. M. Sabater, J.M. Moreno-Navarrete, F.J. Ortega, G. Pardo, J. Salvador, and W. Ricart et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss Journal of Clinical Endocrinology and Metabolism 95 10 2010 4720 4728
34. D. Stejskal, M. Karpisek, M. Svestak, P. Hejduk, L. Sporova, and H. Kotolova Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population Journal of Clinical Laboratory Analysis 24 1 2010 17 19
35. N. Tahara, S. Yamagishi, A. Tahara, Y. Nitta, N. Kodama, and M. Mizoguchi et al. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans Atherosclerosis 219 1 2011 311 315
36. N. Tahara, S. Yamagishi, A. Tahara, M. Takeuchi, and T. Imaizumi Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans Clinical Biochemistry 45 16-17 2012 1404 1408
37. J. Tombran-Tink, and C.J. Barnstable PEDF: A multifaceted neurotrophic factor Nature Reviews. Neuroscience 4 8 2003 628 636
38. J.J. Wang, S.X. Zhang, K. Lu, Y. Chen, R. Mott, and S. Sato et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy Diabetes 54 1 2005 243 250
39. J.J. Wang, S.X. Zhang, R. Mott, R.R. Knapp, W. Cao, and K. Lau et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: Evidence for antifibrogenic activities Diabetes 55 6 2006 1678 1685
40. J.J. Wang, S.X. Zhang, R. Mott, Y. Chen, R.R. Knapp, and W. Cao et al. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy American Journal of Physiology. Renal Physiology 294 5 2008 F1166 F1173
41. Y. Wang, P.T. Katzmarzyk, R. Horswell, W. Li, K. Xiao, and J. Besse et al. Racial disparities in diabetic complications in an underinsured population Journal of Clinical Endocrinology and Metabolism 2012
42. F. Wang, X. Ma, M. Zhou, X. Pan, J. Ni, and M. Gao et al. Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease Cardiovascular Diabetology 12 2013 56
43. S.I. Yamagishi, and T. Matsui Anti-atherothrombogenic properties of PEDF Current Molecular Medicine 10 3 2010 284 291
44. S. Yamagishi, T. Matsui, and K. Nakamura Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders Current Pharmaceutical Design 15 9 2009 1027 1033
45. S. Yamagishi, H. Adachi, A. Abe, T. Yashiro, M. Enomoto, and K. Furuki et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome Journal of Clinical Endocrinology and Metabolism 91 6 2006 2447 2450
46. S. Yamagishi, T. Matsui, K. Nakamura, S. Ueda, Y. Noda, and T. Imaizumi Pigment epithelium-derived factor (PEDF): Its potential therapeutic implication in diabetic vascular complications Current Drug Targets 9 11 2008 1025 1029
47. S.I. Yamagishi, T. Matsui, T. Kawaguchi, and M. Sata Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders Current Medicinal Chemistry 17 19 2010 1995 2000
48. S.X. Zhang, J.J. Wang, G. Gao, K. Parke, and J.X. Ma et al. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy Journal of Molecular Endocrinology 37 1 2006 1 12
49. S.X. Zhang, J.J. Wang, A. Dashti, K. Wilson, M.H. Zou, and L. Szweda et al. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein Journal of Molecular Endocrinology 41 3 2008 135 143
50. M.S. Zhou, I.H. Schulman, K. Chadipiralla, and L. Raij et al. Role of c-Jun N-terminal kinase in the regulation of vascular tone Journal of Cardiovascular Pharmacology and Therapeutics 15 1 2010 78 83
51. X.F. Zhu, and H.D. Zou PEDF in diabetic retinopathy: A protective effect of oxidative stress Journal of Biomedicine & Biotechnology 2012 2012 580687